title: Vasodilatory responsiveness to adenosine triphosphate in ageing humans.
abstract: Endothelium-dependent vasodilatation is reduced with advancing age in humans, as evidenced by blunted vasodilator responsiveness to acetylcholine (ACh). Circulating adenosine triphosphate (ATP) has been implicated in the control of skeletal muscle vascular tone during mismatches in oxygen delivery and demand (e.g. exercise) via binding to purinergic receptors (P2Y) on the endothelium evoking subsequent vasodilatation, and ageing is typically associated with reductions in muscle blood flow under such conditions. Therefore, we tested the hypothesis that ATP-mediated vasodilatation is impaired with age in healthy humans. We measured forearm blood flow (venous occlusion plethysmography) and calculated vascular conductance (FVC) responses to local intra-arterial infusions of ACh, ATP, and sodium nitroprusside (SNP) before and during ascorbic acid (AA) infusion in 13 young and 13 older adults. The peak increase in FVC to ACh was significantly impaired in older compared with young adults (262 ± 71% vs. 618 ± 97%; P < 0.05), and this difference was abolished during AA infusion (510 ± 82% vs. 556 ± 71%; not significant, NS). In contrast, peak FVC responses were not different between older and young adults to either ATP (675 ± 105% vs. 734 ± 126%) or SNP (1116 ± 111% vs. 1138 ± 148%) and AA infusion did not alter these responses in either age group (both NS). In another group of six young and six older adults, we determined whether vasodilator responses to adenosine and ATP were influenced by P1-receptor blockade via aminophylline. The peak FVC responses to adenosine were not different in young (350 ± 65%) versus older adults (360 ± 80%), and aminophylline blunted these responses by ∼50% in both groups. The peak FVC responses to ATP were again not different in young and older adults, and aminophylline did not impact the vasodilatation in either group. Thus, in contrast to the observed impairments in ACh responses, the vasodilatory response to exogenous ATP is not reduced with age in healthy humans. Further, our data also indicate that adenosine mediated vasodilatation is not reduced with age, and that ATP-mediated vasodilatation is independent of P1-receptor stimulation in both young and older adults.
authors.affiliation: Human Cardiovascular Physiology Laboratory, Department of Health and Exercise Science, Colorado State University, Fort Collins, CO 80523-1582, USA.
authors.forename: Brett S
authors.initials: BS
authors.lastname: Kirby
authors.forename: Anne R
authors.initials: AR
authors.lastname: Crecelius
authors.forename: Wyatt F
authors.initials: WF
authors.lastname: Voyles
authors.forename: Frank A
authors.initials: FA
authors.lastname: Dinenno
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000367:Age Factors; D000368:Aged; D000375:Aging / Q000502:physiology*; D000628:Aminophylline / Q000494:pharmacology; D001205:Ascorbic Acid / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D004562:Electrocardiography; D005260:Female; D005542:Forearm / Q000098:blood supply* / Q000502:physiology; D006801:Humans; D007261:Infusions, Intra-Arterial; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000098:blood supply / Q000502:physiology; D009599:Nitroprusside / Q000494:pharmacology; D010991:Plethysmography; D058915:Purinergic P1 Receptor Antagonists / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects* / Q000502:physiology; D014664:Vasodilation / Q000187:drug effects* / Q000502:physiology; D014665:Vasodilator Agents / Q000494:pharmacology; D055815:Young Adult
chemical_list: D058915:Purinergic P1 Receptor Antagonists; D014665:Vasodilator Agents; D009599:Nitroprusside; D000628:Aminophylline; D000255:Adenosine Triphosphate; D000109:Acetylcholine; D001205:Ascorbic Acid
references.citation: Circulation. 2002 Sep 10;106(11):1349-54
references.pmid: 12221051
references.citation: J Physiol. 2004 Jul 1;558(Pt 1):351-65
references.pmid: 15155791
references.citation: Ann N Y Acad Sci. 2004 Dec;1031:425-7
references.pmid: 15753187
references.citation: J Physiol. 2002 Jun 1;541(Pt 2):623-35
references.pmid: 12042366
references.citation: J Physiol. 2008 Sep 1;586(17):4033-4
references.pmid: 18765518
references.citation: Med Sci Sports Exerc. 2004 Jan;36(1):35-41
references.pmid: 14707765
references.citation: Hypertension. 2008 Jul;52(1):80-5
references.pmid: 18504327
references.citation: Am J Physiol. 1996 Dec;271(6 Pt 2):H2717-22
references.pmid: 8997335
references.citation: Med Sci Sports Exerc. 1995 Aug;27(8):1158-64
references.pmid: 7476060
references.citation: Circulation. 2000 Sep 19;102(12):1351-7
references.pmid: 10993851
references.citation: Experientia. 1995 Mar 15;51(3):256-9
references.pmid: 7698289
references.citation: FEBS J. 2007 Jun;274(11):2707-14
references.pmid: 17451439
references.citation: J Physiol. 2009 May 1;587(Pt 9):1989-2003
references.pmid: 19307300
references.citation: J Physiol. 2007 Feb 15;579(Pt 1):227-36
references.pmid: 17138603
references.citation: Br Med Bull. 1963 May;19:101-9
references.pmid: 13950177
references.citation: Microcirculation. 2006 Jun;13(4):315-27
references.pmid: 16611597
references.citation: Am J Physiol. 1988 May;254(5 Pt 2):H828-32
references.pmid: 3364587
references.citation: Am J Physiol. 1998 Nov;275(5):H1726-32
references.pmid: 9815080
references.citation: Circulation. 1990 Feb;81(2):491-7
references.pmid: 2105174
references.citation: J Physiol. 2008 Oct 15;586(20):4993-5002
references.pmid: 18703581
references.citation: Pharmacol Rev. 1998 Sep;50(3):413-92
references.pmid: 9755289
references.citation: Br J Pharmacol. 2004 Mar;141(5):842-50
references.pmid: 14769779
references.citation: J Physiol. 2008 Sep 1;586(17):4305-16
references.pmid: 18617568
references.citation: Circ Res. 2002 Nov 29;91(11):1046-55
references.pmid: 12456491
references.citation: Circulation. 1998 Jun 9;97(22):2222-9
references.pmid: 9631871
references.citation: J Physiol. 2007 Jul 1;582(Pt 1):335-47
references.pmid: 17478526
references.citation: J Physiol. 2003 Aug 15;551(Pt 1):337-44
references.pmid: 12824451
references.citation: Physiology (Bethesda). 2009 Apr;24:107-16
references.pmid: 19364913
references.citation: J Mol Cell Cardiol. 1999 Jan;31(1):23-37
references.pmid: 10072713
references.citation: Am J Physiol Heart Circ Physiol. 2001 Jun;280(6):H2616-22
references.pmid: 11356617
references.citation: Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2576-84
references.pmid: 15271659
references.citation: Circulation. 2009 Jan 27;119(3):480-6
references.pmid: 19171871
references.citation: J Appl Physiol (1985). 1999 Dec;87(6):2218-24
references.pmid: 10601170
references.citation: Biofactors. 2007;31(2):77-98
references.pmid: 18806312
references.citation: Clin Sci (Lond). 1997 Feb;92(2):123-31
references.pmid: 9059312
references.citation: Circulation. 2006 Apr 4;113(13):1708-14
references.pmid: 16585403
references.citation: Am J Physiol. 1995 Dec;269(6 Pt 2):H2155-61
references.pmid: 8594927
references.citation: J Physiol. 2002 Jul 1;542(Pt 1):255-62
references.pmid: 12096067
references.citation: Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1586-90
references.pmid: 15563530
references.citation: Annu Rev Med. 1996;47:315-31
references.pmid: 8712785
references.citation: Diabetes Res Clin Pract. 2008 Sep;81(3):351-7
references.pmid: 18644642
references.citation: Thromb Haemost. 2001 May;85(5):875-81
references.pmid: 11372682
references.citation: Circulation. 1990 Feb;81(2):482-90
references.pmid: 2105173
references.citation: Eur Heart J. 1997 Nov;18 Suppl E:E19-29
references.pmid: 9402468
references.citation: Circulation. 1994 Oct;90(4):1891-8
references.pmid: 7923677
references.citation: Hypertension. 2001 Aug;38(2):274-9
references.pmid: 11509489
references.citation: Cardiovasc Res. 1992 Jan;26(1):40-7
references.pmid: 1325292
references.citation: Hypertension. 1994 Jun;23(6 Pt 2):1113-20
references.pmid: 8206602
references.citation: J Physiol. 2005 Aug 15;567(Pt 1):311-21
references.pmid: 15946964
references.citation: Biochim Biophys Acta. 2008 May;1783(5):673-94
references.pmid: 18302942
references.citation: Ann N Y Acad Sci. 1990;603:31-44; discussion 44-5
references.pmid: 2291529
references.citation: Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1140-8
references.pmid: 19118095
references.citation: J Physiol. 1969 Jan;200(1):53P-4P
references.pmid: 5761975
references.citation: Am J Cardiol. 1998 Dec 15;82(12):1535-9, A7-8
references.pmid: 9874063
references.citation: Am J Physiol Heart Circ Physiol. 2003 Apr;284(4):H1251-9
references.pmid: 12595287
references.citation: Clin Sci (Lond). 1990 Jan;78(1):89-93
references.pmid: 2153501
references.citation: J Appl Physiol (1985). 2006 Dec;101(6):1678-84
references.pmid: 16946029
references.citation: J Am Coll Cardiol. 1994 Aug;24(2):471-6
references.pmid: 8034885
references.citation: Clin Sci. 1972 May;42(5):555-65
references.pmid: 5032887